TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 201 filers reported holding TG THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,632 | -57.8% | 195,167 | +25.4% | 0.02% | -48.4% |
| Q2 2023 | $3,866 | +992.1% | 155,648 | +560.5% | 0.03% | +933.3% |
| Q1 2023 | $354 | -100.0% | 23,565 | -82.7% | 0.00% | -72.7% |
| Q3 2022 | $805,000 | +257.8% | 136,021 | +157.4% | 0.01% | +266.7% |
| Q2 2022 | $225,000 | -51.3% | 52,853 | +8.7% | 0.00% | -50.0% |
| Q1 2022 | $462,000 | +260.9% | 48,630 | +112.6% | 0.01% | +50.0% |
| Q3 2019 | $128,000 | -35.0% | 22,877 | +0.4% | 0.00% | -50.0% |
| Q2 2019 | $197,000 | – | 22,796 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |